tiprankstipranks
Psyence Group Sells Stake to Psyence Biomedical
Company Announcements

Psyence Group Sells Stake to Psyence Biomedical

Psyence Biomedical (PBM) has released an update.

Don't Miss our Black Friday Offers:

Psyence Group Inc. has agreed to sell a portion of its shares in Psyence Labs Ltd. to Psyence Biomedical Ltd., with the transaction expected to be finalized by October 31, 2024. The sale, representing an 11.13% stake in the company, is contingent upon board approvals and a satisfactory due diligence process by the purchaser. The agreement also includes the production of a psilocybin batch as a condition precedent to the sale.

For further insights into PBM stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyPsyence Biomedical Ltd trading halted, news pending
Sheryl ShethUpcoming Stock Splits This Week (November 25 to November 29) – Stay Invested
TheFlyPsyence announces favorable result on Nasdaq listing qualifications hearing
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App